Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

Red blood cell transfusions remain one of the cornerstones in supportive care of lower-risk patients with myelodysplastic syndromes. We hypothesized that patients develop oxidant-mediated tissue injury through the formation of toxic iron species, caused either by red blood cell transfusions or by in...

Descripción completa

Detalles Bibliográficos
Autores principales: de Swart, Louise, Reiniers, Chloé, Bagguley, Timothy, van Marrewijk, Corine, Bowen, David, Hellström-Lindberg, Eva, Tatic, Aurelia, Symeonidis, Argiris, Huls, Gerwin, Cermak, Jaroslav, van de Loosdrecht, Arjan A., Garelius, Hege, Culligan, Dominic, Macheta, Mac, Spanoudakis, Michail, Panagiotidis, Panagiotis, Krejci, Marta, Blijlevens, Nicole, Langemeijer, Saskia, Droste, Jackie, Swinkels, Dorine W., Smith, Alex, de Witte, Theo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777192/
https://www.ncbi.nlm.nih.gov/pubmed/29122992
http://dx.doi.org/10.3324/haematol.2017.171884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777192/
https://www.ncbi.nlm.nih.gov/pubmed/29122992
http://dx.doi.org/10.3324/haematol.2017.171884

Ejemplares similares